Mobilization of Ca+2 from intracellular stores is an important signaling
mechanism in cells and is mediated by two major mechanisms, the inositol
trisphosphate (IP3) pathway and the Ca+2-induced Ca+2 release (CICR)
process. We have identified a Ca+2 mobilization system in sea urchin eggs
which is totally independent of the IP3 pathway. This system is activated
by a metabolite of NAD+ we called cyclic ADP-ribose (cADPR). In addition
to sea urchin eggs, several mammalian cell types have been shown to be
responsive to cADPR, indicating the generality of the mechanism.
Increasing evidence suggests that cADPR may be an endogenous regulator of
CICR in cells. Three recent advances indicate that the cADPR mechanism is
tightly regulated. First, the synthetic pathway of cADPR has been shown to
be stimulated by a cGMP-dependent mechanism. Second, a lymphocyte protein
called CD38 has been shown to be a bifunctional enzyme that can catalyze
both the synthesis and hydrolysis of cADPR and third, a soluble protein
factor has been shown to be required for conferring the cADPR-sensitivity
to microsomes.
The proposed research will examine the regulation mechanisms of the cADPR
pathway. (l) The soluble protein factors from brain and sea urchin eggs
that confer the cADPR sensitivity to egg microsomes will be purified and
characterized. We will investigate the possibilities that the soluble
factor functions as a sensitizer of the cADPR-receptor to cADPR and/or the
Ca+2 release mechanism to Ca+2. (2) The cGMP-dependent regulation
mechanism of ADP-ribosyl cyclase and CD38 will be elucidated. We will use
direct photoaffinity labeling and protein sequencing to identify the
components involved in mediating the stimulatory effect of cGMP on the
synthetic pathway of cADPR. (3) The enzymatic mechanisms of ADP-ribosyl
cyclase and CD38 will be investigated. We will examine the formation of
the ADP-ribosylated enzyme intermediates and identify the catalytic sites
of the enzymes by photoaffinity labeling. (4) Finally, we will extend the
results obtained from egg microsomes to intact eggs and to mammalian brain
microsomes.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
555917996
UEI
KABJZBBJ4B54
Project Start Date
15-July-1994
Project End Date
30-April-1998
Budget Start Date
15-July-1994
Budget End Date
30-April-1995
Project Funding Information for 1994
Total Funding
$151,355
Direct Costs
$115,123
Indirect Costs
$36,232
Year
Funding IC
FY Total Cost by IC
1994
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$151,355
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01HD032040-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01HD032040-01
Patents
No Patents information available for 1R01HD032040-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01HD032040-01
Clinical Studies
No Clinical Studies information available for 1R01HD032040-01
News and More
Related News Releases
No news release information available for 1R01HD032040-01
History
No Historical information available for 1R01HD032040-01
Similar Projects
No Similar Projects information available for 1R01HD032040-01